Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Natus Medical Inc Reaffirms Q3, FY 2012 Guidance-Conference Call
Natus Medical Inc announced that for fiscal 2012, it expects revenue in the range of $295 million to $300 million with earnings of $0.58 to $0.63. For the third quarter of 2012, it expects revenue in the range of $80 million to $82 million and EPS in the range of $0.12 to $0.14. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $295 million and EPS of $0.60 for fiscal 2012; revenue of $81 million and EPS of $0.13 for the third quarter of 2012.
Latest Developments for Natus Medical Inc
- Natus Medical Inc Reaffirms Q2 2013 Guidance; Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance
- Natus Medical Inc Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance; Issues Q2 2013 Guidance In Line With Analysts' Estimates
- Natus Medical Inc Reaffirms FY, Q1 2013 Guidance
- Natus Medical Inc Issues FY 2013 Guidance Above Analysts' Estimates; Issues Q1 2013 Mixed Guidance
Latest Key Developments in Advanced
- Edap Tms SA Receives CE Mark For Focal.one
- Andor Technology plc Issues FY 2013 Revenue Guidance Below Analysts' Estimates-DJ
- Boston Scientific Corp's Vercise DBS System Demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
- USCOM Ltd Completes Pulsecor Asset Purchase and Acquires New BP+ Central Blood Pressure Device
- Share this
- Link this
- Digg this
Follow Reuters